ALLMedicine™ Paracentesis Center

Feb 27th, 2021 - The primary aim of this study was to evaluate the activity of intraperitoneal bevacizumab (IP-bev) in delaying re-accumulation of malignant ascites in women with chemotherapy-resistant epithelial ovarian cancer (CR-EOC) who have ceased chemotherap...

Feb 5th, 2021 - A 54-year-old Chinese man presented with ascites for 2 weeks. He had a preceding 2-year history of intermittent dysphagia, lethargy and general malaise. Blood investigations revealed leucocytosis with eosinophilia of 26.5%, whereas paracentesis sh...

Jan 19th, 2021 - With a potentially life-threatening course, acute pancreatitis (AP) is one of the most common gastrointestinal diseases requiring hospitalization and often necessitating intensive care. Based on recent insights and recommendations, this review pro...

Jan 4th, 2021 - Variation in Paracentesis Practice in the United Kingdom Could Endanger Patient Safety.|2021|Droste J,Riggott C,|

Dec 21st, 2020 - Palliative care remains suboptimal in end-stage liver disease (ESLD). We report qualitative outcomes from the REDUCe study. We aimed to explore and contrast experiences/perceptions/care pathways of patients with refractory ascites due to ESLD rand...

Feb 27th, 2021 - The primary aim of this study was to evaluate the activity of intraperitoneal bevacizumab (IP-bev) in delaying re-accumulation of malignant ascites in women with chemotherapy-resistant epithelial ovarian cancer (CR-EOC) who have ceased chemotherap...

Feb 5th, 2021 - A 54-year-old Chinese man presented with ascites for 2 weeks. He had a preceding 2-year history of intermittent dysphagia, lethargy and general malaise. Blood investigations revealed leucocytosis with eosinophilia of 26.5%, whereas paracentesis sh...

Jan 19th, 2021 - With a potentially life-threatening course, acute pancreatitis (AP) is one of the most common gastrointestinal diseases requiring hospitalization and often necessitating intensive care. Based on recent insights and recommendations, this review pro...

Jan 4th, 2021 - Variation in Paracentesis Practice in the United Kingdom Could Endanger Patient Safety.|2021|Droste J,Riggott C,|

Dec 21st, 2020 - Palliative care remains suboptimal in end-stage liver disease (ESLD). We report qualitative outcomes from the REDUCe study. We aimed to explore and contrast experiences/perceptions/care pathways of patients with refractory ascites due to ESLD rand...

Aug 15th, 2019 - Answer 4/5 According to guidelines from the European Association for the Study of the Liver (EASL), which of the following is recommended for the management of ascites in patients with decompensated cirrhosis? Your peers chose: Liver transplantati...

Jul 1st, 2019 - Cirrhosis can involve “precarious” changes in hemostatic pathways that tip the scales toward either bleeding or hypercoagulation, experts wrote in an American Gastroenterological Association Clinical Practice Update. Based on current evidence, cli.

Feb 27th, 2018 - To the Editor: A 40-year-old woman with a history of stage IIIC ovarian cancer presented with progressing abdominal erythema and pain of 1 month’s duration. She had been diagnosed 4 years prior with grade 3, poorly differentiated papillary serous.

Jan 1st, 2017 - One-year survival without liver transplant was far more likely when transjugular intrahepatic portosystemic shunts (TIPS) with covered stents were used to treat cirrhosis with recurrent ascites, instead of ongoing large-volume paracenteses with al.

Jul 1st, 2014 - A 51-year-old man with end-stage liver disease from alcohol abuse presented with worsening dyspnea on exertion. He had a history of ascites requiring diuretic therapy and intermittent paracentesis, as well as symptomatic hepatic hydrothorax requir.